Fisher Asset Management
TAK icon

Fisher Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Fisher Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,484
Closed -$593K – 1098
2025
Q3 		$593K Sell
40,484
-58,151
-59% -$864K ﹤0.01% 754
2025
Q2 		$1.52M Buy
98,635
+46,490
+89% +$687K ﹤0.01% 619
2025
Q1 		$775K Buy
52,145
+10,811
+26% +$151K ﹤0.01% 724
2024
Q4 		$547K Buy
+41,334
New +$568K ﹤0.01% 764
2021
Q4 		– Sell
-10,339
Closed -$169K – 998
2021
Q3 		$169K Buy
+10,339
New +$174K ﹤0.01% 887

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management's TAK Position: Q4 2025 in Review

Fisher Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2025, closing a stake of 40,484 shares — an estimated $593K sold.

Fisher Asset Management first reported a position in TAK in Q3 2021 and held it in 5 quarters. The position peaked at $1.52M in Q2 2025. 349 funds tracked by Wall St. Rank hold TAK as of Q4 2025.

  • Fisher Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Fisher Asset Management sold 40,484 Takeda Pharmaceutical shares in Q4 2025, an estimated $593K.
  • Fisher Asset Management first reported a position in Takeda Pharmaceutical in Q3 2021 and held it in 5 quarters.
  • Fisher Asset Management's Takeda Pharmaceutical position peaked at $1.52M in Q2 2025.
  • 349 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.